CYSTADANE
Google image searchProduct monograph
Active ingredient
betaine, 1 G/1.7 CC
DIN: 02238526
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: ORAL
Schedule: Prescription
Company: RECORDATI RARE DISEASES CANADA INC
Date: 17-JAN-2020
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AA — Amino acids and derivatives (ATC, ATC/DDD)
- A16AA06 — BETAINE (ATC/DDD)
Reference brand drug: Cystadane
Pharmaceutical standard: MFR
